Immatics N.V. announced updated Phase 1 data for its IMA203CD8 PRAME TCR T-cell therapy across multiple solid tumor types. As of the August 7, 2026 data cutoff, 98 heavily pretreated patients across ...

Thirty-five years after Vin Scully compared a 5-foot-6 shortstop to something that fell out of Kent Hrbek’s pocket, Jon “Boog ...

Let's take a look in our On Paper Lions vs. Packers preview and prediction. The Lions' passing attack continues to be one of ...

Got a future author at home? A free Corpus Christi workshop is helping teens get creative, build confidence and tell their ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. MILLBRAE, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- ...

From 5-7 p.m. Wednesday, Oct. 28, Black Hawk College East Campus will be transformed into a haunted, trick-or-treat ...

Honors and recognition, academic achievement, facility planning and future athletic opportunities were among the topics ...

Among 37 patients, none had dose-limiting toxicities or stopped PAS-004 for treatment-related side effects. Data are being ...

The 5th GMIF Innovation Summit (Global Memory Innovation Forum 2026, GMIF2026), co-hosted by the Shenzhen Memory Industry ...

Napoleon Area City Schools Board of Education acknowledged a property tax agreement for an expanding company during its meeting Wednesday and recognized students with perfect test scores ...